Axsome Therapeutics Inc (AXSM)
71.10
+3.20
(+4.71%)
USD |
NASDAQ |
Apr 22, 16:00
71.12
+0.02
(+0.04%)
After-Hours: 20:00
Axsome Therapeutics Debt to Equity Ratio: 0.9324 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.9324 |
| September 30, 2023 | 0.6584 |
| June 30, 2023 | 0.6342 |
| March 31, 2023 | 1.320 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.8604 |
| September 30, 2022 | 0.5968 |
| June 30, 2022 | 6.149 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5968
Minimum
Sep 2022
6.149
Maximum
Jun 2022
1.593
Average
0.8604
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Amgen Inc | 10.37 |
| Johnson & Johnson | 0.4265 |
| ResMed Inc | 0.2737 |
| Vertex Pharmaceuticals Inc | 0.00 |
| Krystal Biotech Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 588.24M |
| Total Liabilities (Quarterly) | 397.26M |
| Shareholders Equity (Quarterly) | 190.98M |
| Current Ratio | 3.632 |
| Net Debt Paydown Yield | -0.45% |